KARA SUE GOODING PA C NPI 1538155320

NPI Details

Kara Sue Gooding, PA C is a physician assistant in Scottsdale, AZ with 26 years of experience. The provider is a physician assistant is a person who has successfully completed an accredited education program for physician assistant, is licensed by the state and is practicing within the scope of that license. Physician assistants are formally trained to perform many of the routine, time-consuming tasks a physician can do. In some states, they may prescribe medications. They take medical histories, perform physical exams, order lab tests and x-rays, and give inoculations. Most states require that they work under the supervision of a physician. Kara Sue Gooding, PA C NPI is 1538155320. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

14275 N 87TH ST
SUITE 110
SCOTTSDALE, AZ
ZIP 85260-696
Phone: (480) 905-8485
Fax: (480) 905-7274

The NPI 1538155320 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm (HCPCS:17261)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm (HCPCS:11301)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:17272)
• Destruction of precancer skin growth, 15 or more growths (HCPCS:17004)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm (HCPCS:17271)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:17281)
• Biopsy of ear (HCPCS:69100)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11602)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm (HCPCS:12032)
• Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm (HCPCS:11302)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:11311)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 9/27/2005 and was last updated on 3/4/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.